Oxycodone News and Research

RSS
Medical researchers use social media to study harmful side effects of narcotics medication

Medical researchers use social media to study harmful side effects of narcotics medication

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

FDA approves Narcan nasal spray to prevent or reverse effects of opioid overdose

Prescription opioids overprescribed in some regions of British Columbia, UBC study finds

Prescription opioids overprescribed in some regions of British Columbia, UBC study finds

Study: Pediatric patients prescribed more opioid medication than necessary following surgery

Study: Pediatric patients prescribed more opioid medication than necessary following surgery

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

BDSI announces FDA approval of BUNAVAIL sNDA for manufacturing specification change

FDA accepts Braeburn's resubmission of Probuphine NDA for review

FDA accepts Braeburn's resubmission of Probuphine NDA for review

Study shows half of adolescents misuse their prescription drugs

Study shows half of adolescents misuse their prescription drugs

BioDelivery Sciences and Endo present Phase 2 data on buprenorphine HCl buccal film in patients with chronic pain

BioDelivery Sciences and Endo present Phase 2 data on buprenorphine HCl buccal film in patients with chronic pain

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet announces launch of OXAYDO (oxycodone HCI, USP) Tablets and IMPACT-Rx initiative

Egalet to present scientific data on SPRIX Nasal Spray at Painweek 2015

Egalet to present scientific data on SPRIX Nasal Spray at Painweek 2015

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

Researchers evaluate use of pharmacy-based naloxone education and distribution to fight opioid overdoses

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

Egalet declares pricing of underwritten public offering of common stock

Egalet declares pricing of underwritten public offering of common stock

Research findings may help health care providers curb painkiller misuse

Research findings may help health care providers curb painkiller misuse

1 in 4 people with histories of nicotine use, substance abuse likely to use opioid painkillers long-term

1 in 4 people with histories of nicotine use, substance abuse likely to use opioid painkillers long-term

Egalet reports top-line results from Category 3 HAL study of Egalet-002

Egalet reports top-line results from Category 3 HAL study of Egalet-002

Egalet reports positive results from Category 3 abuse-deterrent intranasal HAL study

Egalet reports positive results from Category 3 abuse-deterrent intranasal HAL study

Adding tamper resistant properties to medications can help curb prescription drug abuse

Adding tamper resistant properties to medications can help curb prescription drug abuse

Opioid offers pain relief for Parkinson’s patients

Opioid offers pain relief for Parkinson’s patients

Wockhardt obtains final approval from FDA for marketing 5mg/ 5ml of Oxycodone HCl liquid

Wockhardt obtains final approval from FDA for marketing 5mg/ 5ml of Oxycodone HCl liquid